Clinical Updates & Insights

Share
Print

Our clinical updates provide you with timely information about Memorial Sloan Kettering’s new treatment approaches, key clinical trials, and innovations in detecting and treating many cancers.

Stay Informed
Get the latest information on MSK’s cancer treatments and research sent straight to your inbox with our monthly clinical updates e-newsletter OncoNotes.
Newsletter Sign Up

Manage Preferences

186 Clinical Updates found

Clinical Update

Epidural Analgesia Unnecessary in Minimally Invasive Lobectomy

The routine use of epidural analgesia for patients with non-small cell lung cancer who undergo a minimally invasive lobectomy is not warranted.

  • Wednesday, January 8, 2020

Clinical Update

Managing Hypertension in Patients Treated with Ibrutinib for Chronic Lymphocytic Leukemia

Blood pressure should be monitored closely and on an ongoing basis for several months after initiating ibrutinib treatment in patients with chronic lymphocytic leukemia (CLL), according to our retrospective study.

  • Wednesday, January 8, 2020

Clinical Update

Axillary MRI Is No Better than a Clinical Exam Alone in Predicting Breast Cancer in Sentinel Nodes after Neoadjuvant Chemotherapy

Magnetic resonance imaging (MRI) of the axilla after neoadjuvant chemotherapy is no more accurate than a clinical exam alone in predicting sentinel lymph node pathology in breast cancer patients with clinical N1 disease.

  • Tuesday, December 10, 2019

Clinical Update

MSK Investigators Create a Highly Accurate Liquid Biopsy for Identifying Early-Stage HPV-Associated Oral and Anal Cancers

At MSK we have developed a highly accurate, low-cost assay, for identifying early-stage oral and anal cancers associated with human papillomavirus (HPV) using liquid biopsy.

  • Tuesday, December 10, 2019

Clinical Update

Reducing Radiation for Select Patients with HPV-Associated Mouth and Throat Cancer

Human papillomavirus (HPV)–associated oropharyngeal cancer is on the rise, but at Memorial Sloan Kettering Cancer Center, we have updated our standard of care to substantially reduce the radiation dose to elective regions.

  • Tuesday, December 10, 2019

Clinical Update

Systemic Therapy for Locally Advanced and Metastatic Non-Small Cell Lung Cancer

Improved understanding of the biology and molecular subtypes of non-small cell lung cancer (NSCLC) has led to the development of several biomarker-targeted therapies for patients with locally advanced and metastatic disease.

  • Monday, November 11, 2019

Clinical Update

What Comes First — Neoadjuvant Chemotherapy or Re-Resection for Patients with Incidental Gallbladder Cancer?

At Memorial Sloan Kettering Cancer Center, more than half of patients with gallbladder cancer are diagnosed incidentally following elective cholecystectomy for assumed benign disease. The traditional treatment approach for these patients is re-resection to achieve a cure.

  • Monday, November 11, 2019

Clinical Update

Rise of the Mutant Clones: A Newly Recognized Risk Factor for CVD

Up to 20 percent of people over the age of 70 have clonal hematopoiesis of indeterminate potential (CHIP), a condition that carries twice the risk of coronary heart disease and ischemic stroke, and worse outcomes after heart failure — independent of traditional cardiovascular risk factors.

  • Tuesday, October 8, 2019

Clinical Update

Testosterone Recovery Uncertain after Androgen Deprivation Therapy for Prostate Cancer

Androgen deprivation therapy may depress testosterone for prolonged periods in older patients, or those who are on the treatment for more than six months, increasing the risk of associated adverse events, according to the results of our recent retrospective study.

  • Tuesday, October 8, 2019

Clinical Update

Immunotherapy and Efficacy of Chemo in Patients with Recurrent Ovarian Cancer

Chemotherapy after immune checkpoint inhibitors (ICIs) may improve survival rates in patients with heavily pretreated, recurrent ovarian cancer.

  • Thursday, September 19, 2019